Does TRASTUZUMAB EMTANSINE Cause Hepatic function abnormal? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hepatic function abnormal have been filed in association with TRASTUZUMAB EMTANSINE (KADCYLA). This represents 3.3% of all adverse event reports for TRASTUZUMAB EMTANSINE.
6
Reports of Hepatic function abnormal with TRASTUZUMAB EMTANSINE
3.3%
of all TRASTUZUMAB EMTANSINE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Hepatic function abnormal From TRASTUZUMAB EMTANSINE?
Of the 6 reports, 4 (66.7%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
Yes, Hepatic function abnormal is listed as a known adverse reaction in the official FDA drug label for TRASTUZUMAB EMTANSINE.
What Other Side Effects Does TRASTUZUMAB EMTANSINE Cause?
Myelosuppression (38)
Disease progression (20)
Platelet count decreased (16)
Metastases to central nervous system (11)
Pneumonia (7)
Thrombocytopenia (7)
Anaemia (6)
Decreased appetite (6)
Aspartate aminotransferase increased (5)
Nausea (5)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which TRASTUZUMAB EMTANSINE Alternatives Have Lower Hepatic function abnormal Risk?
TRASTUZUMAB EMTANSINE vs TRASTUZUMAB-PKRB
TRASTUZUMAB EMTANSINE vs TRASTUZUMAB-QYYP
TRASTUZUMAB EMTANSINE vs TRAVOPROST
TRASTUZUMAB EMTANSINE vs TRAZODONE
TRASTUZUMAB EMTANSINE vs TREANDA